Condition: Tako Tsubo Cardiomyopathy · Microvascular Dysfunction · CD34+ Stem Cells · Sponsor: University Medical Centre Ljubljana
The underlying mechanisms of microvascular dysfunction in Takotsubo cardiomyopathy remain incompletely understood. As CD34+ cells are essential to coronary microvascular homeostasis we will investigate the potential association between CD34+ cell count and changes in left ventricular function in patients with Takotsubo cardiomyopathy at baseline and 6-month follow-up.
This description comes directly from the study's public registry record.
Mark Jovanović, MD · +38640977307 · mark.jovanovic@kclj.si
Principal Investigator · gregor.poglajen@kclj.si
Always discuss trial participation with your own doctor first.
| Advanced Heart Failure and Transplantation Program, Department of Cardiology, UMC Ljubljana, Slovenia | Ljubljana, Ljubljana, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07604467